Clinical Gastroenterology and Hepatology · In press · Journal article · DOI 10.1016/j.cgh.2026.02.018 · Cited by 5 (Crossref)
Remo Panaccione, Julián Panés, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel, James O. Lindsay, Filip Baert, Raja Atreya, Séverine Vermeire, Toshimitsu Fujii, Elena Dubcenco, Justin Klaff, Benjamin Duncan, Smitha Suravaram, Irina Fish, Ana P. Lacerda, Ramona Vladea, Sharanya Ford, Saajan Shah, Samuel I. Anyanwu, David T Rubin
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Panaccione, R., Panés, J., Peyrin-Biroulet, L., et al. (2026). Long-Term Safety of Upadacitinib in Patients With Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.02.018